Results 191 to 200 of about 13,750 (216)
Some of the next articles are maybe not open access.
Deutsche medizinische Wochenschrift (1946), 1993
A 17-year-old girl developed acute colicky periumbilical pain with haematuria. On examination a tightly elastic space-occupying lesion about 10 cm in diameter was palpable around the umbilicus. Erythrocyte sedimentation rate (ESR) was raised to 113 mm in the first hour.
M, Genoni +7 more
openaire +1 more source
A 17-year-old girl developed acute colicky periumbilical pain with haematuria. On examination a tightly elastic space-occupying lesion about 10 cm in diameter was palpable around the umbilicus. Erythrocyte sedimentation rate (ESR) was raised to 113 mm in the first hour.
M, Genoni +7 more
openaire +1 more source
1992
Castleman’s disease (giant lymphoid hamartoma, angiofollicular mediastinal lymph node hyperplasia, angiomatous lymphoid hamartoma) was originally described as a localized benign mediastinal lymph node enlargement characterized by angiofollicular hyperplasia and interfollicular capillary proliferation (Castleman et al.. 1956).
J. M. Verley, K. H. Hollmann
openaire +1 more source
Castleman’s disease (giant lymphoid hamartoma, angiofollicular mediastinal lymph node hyperplasia, angiomatous lymphoid hamartoma) was originally described as a localized benign mediastinal lymph node enlargement characterized by angiofollicular hyperplasia and interfollicular capillary proliferation (Castleman et al.. 1956).
J. M. Verley, K. H. Hollmann
openaire +1 more source
2018
Castleman’s disease (CD) is a rare and relatively unknown lymphoproliferative disorder, with benign hyperplastic lymph nodes. The disease was first reported in 1956 by Benjamin Castleman, a pathologist from the Massachusetts General Hospital (Castleman and Towne, N Engl J Med 250:1001–1005, 1954).
Anne Musters, Sander W. Tas
openaire +1 more source
Castleman’s disease (CD) is a rare and relatively unknown lymphoproliferative disorder, with benign hyperplastic lymph nodes. The disease was first reported in 1956 by Benjamin Castleman, a pathologist from the Massachusetts General Hospital (Castleman and Towne, N Engl J Med 250:1001–1005, 1954).
Anne Musters, Sander W. Tas
openaire +1 more source
Medizinische Klinik (Munich, Germany : 1983), 2000
The term "Castleman's disease" (angiofollicular lymph node hyperplasia) comprises a heterogeneous clinicopathologic entity among lymphoproliferative disorders.We present a rare case with retroperitoneal manifestations, and discuss several aspects of diagnosis, differential diagnosis, the clinical course and therapy of the disease. Finally, we summarize
B, Bleiber, J O, Gebbers, R, Joss
openaire +1 more source
The term "Castleman's disease" (angiofollicular lymph node hyperplasia) comprises a heterogeneous clinicopathologic entity among lymphoproliferative disorders.We present a rare case with retroperitoneal manifestations, and discuss several aspects of diagnosis, differential diagnosis, the clinical course and therapy of the disease. Finally, we summarize
B, Bleiber, J O, Gebbers, R, Joss
openaire +1 more source
2016
Castleman’s disease (CD) is a rare lymphoproliterative disorder of unknown causes, which involves the lymph nodes and less commonly the extranodal tissues.
openaire +1 more source
Castleman’s disease (CD) is a rare lymphoproliterative disorder of unknown causes, which involves the lymph nodes and less commonly the extranodal tissues.
openaire +1 more source
CXCL13 is a predictive biomarker in idiopathic multicentric Castleman disease
Nature Communications, 2022Sheila K Pierson, Melanie D Mumau
exaly
Castleman's tumours and production of autoantibody in paraneoplastic pemphigus
Lancet, The, 2004Liangchun Wang
exaly
Castleman's disease—a two compartment model of HHV8 infection
Nature Reviews Clinical Oncology, 2010Klaus-Martin Schulte
exaly